Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factorial Trial of Glucocorticoid Therapy in ARDS
NCT05401812Phase 2Withdrawn
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2022
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of methylprednisolone injection in acute respiratory distress syndrome (ARDS), sponsored by National Taiwan University Hospital. Planned start Jul 2022; status: withdrawn.
02
Drugs
methylprednisolone injection
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05401812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05401812.